Cargando…

Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition

BACKGROUND: Persisters are rare phenotypic variants within a bacterial population that are capable of tolerating lethal antibiotic concentrations. Passage through stationary phase is associated with the formation of persisters (type I), and a major physiological response of Escherichia coli during s...

Descripción completa

Detalles Bibliográficos
Autores principales: Aedo, Sandra J., Orman, Mehmet A., Brynildsen, Mark P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591824/
https://www.ncbi.nlm.nih.gov/pubmed/31234796
http://dx.doi.org/10.1186/s12866-019-1506-7
_version_ 1783429785973686272
author Aedo, Sandra J.
Orman, Mehmet A.
Brynildsen, Mark P.
author_facet Aedo, Sandra J.
Orman, Mehmet A.
Brynildsen, Mark P.
author_sort Aedo, Sandra J.
collection PubMed
description BACKGROUND: Persisters are rare phenotypic variants within a bacterial population that are capable of tolerating lethal antibiotic concentrations. Passage through stationary phase is associated with the formation of persisters (type I), and a major physiological response of Escherichia coli during stationary phase is cell wall restructuring. Given the concurrence of these processes, we sought to assess whether perturbation to cell wall synthesis during stationary phase impacts type I persister formation. RESULTS: We tested a panel of cell wall inhibitors and found that piperacillin, which primarily targets penicillin binding protein 3 (PBP3 encoded by ftsI), resulted in a significant reduction in both β-lactam (ampicillin, carbenicillin) and fluoroquinolone (ofloxacin, ciprofloxacin) persister levels. Further analyses showed that piperacillin exposure through stationary phase resulted in cells with more ATP, DNA, RNA, and protein (including PBPs) than untreated controls; and that their physiology led to more rapid resumption of DNA gyrase supercoiling activity, translation, and cell division upon introduction into fresh media. Previously, PBP3 inhibition had been linked to antibiotic efficacy through the DpiBA two component system; however, piperacillin suppressed persister formation in ΔdpiA to the same extent as it did in wild-type, suggesting that DpiBA is not required for the phenomenon reported here. To test the generality of PBP3 inhibition on persister formation, we expressed FtsI Ser307Ala to genetically inhibit PBP3, and suppression of persister formation was also observed, although not to the same magnitude as that seen for piperacillin treatment. CONCLUSIONS: From these data we conclude that stationary phase PBP3 activity is important to type I persister formation in E. coli. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12866-019-1506-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6591824
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65918242019-07-08 Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition Aedo, Sandra J. Orman, Mehmet A. Brynildsen, Mark P. BMC Microbiol Research Article BACKGROUND: Persisters are rare phenotypic variants within a bacterial population that are capable of tolerating lethal antibiotic concentrations. Passage through stationary phase is associated with the formation of persisters (type I), and a major physiological response of Escherichia coli during stationary phase is cell wall restructuring. Given the concurrence of these processes, we sought to assess whether perturbation to cell wall synthesis during stationary phase impacts type I persister formation. RESULTS: We tested a panel of cell wall inhibitors and found that piperacillin, which primarily targets penicillin binding protein 3 (PBP3 encoded by ftsI), resulted in a significant reduction in both β-lactam (ampicillin, carbenicillin) and fluoroquinolone (ofloxacin, ciprofloxacin) persister levels. Further analyses showed that piperacillin exposure through stationary phase resulted in cells with more ATP, DNA, RNA, and protein (including PBPs) than untreated controls; and that their physiology led to more rapid resumption of DNA gyrase supercoiling activity, translation, and cell division upon introduction into fresh media. Previously, PBP3 inhibition had been linked to antibiotic efficacy through the DpiBA two component system; however, piperacillin suppressed persister formation in ΔdpiA to the same extent as it did in wild-type, suggesting that DpiBA is not required for the phenomenon reported here. To test the generality of PBP3 inhibition on persister formation, we expressed FtsI Ser307Ala to genetically inhibit PBP3, and suppression of persister formation was also observed, although not to the same magnitude as that seen for piperacillin treatment. CONCLUSIONS: From these data we conclude that stationary phase PBP3 activity is important to type I persister formation in E. coli. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12866-019-1506-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-06-24 /pmc/articles/PMC6591824/ /pubmed/31234796 http://dx.doi.org/10.1186/s12866-019-1506-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Aedo, Sandra J.
Orman, Mehmet A.
Brynildsen, Mark P.
Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition
title Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition
title_full Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition
title_fullStr Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition
title_full_unstemmed Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition
title_short Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition
title_sort stationary phase persister formation in escherichia coli can be suppressed by piperacillin and pbp3 inhibition
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591824/
https://www.ncbi.nlm.nih.gov/pubmed/31234796
http://dx.doi.org/10.1186/s12866-019-1506-7
work_keys_str_mv AT aedosandraj stationaryphasepersisterformationinescherichiacolicanbesuppressedbypiperacillinandpbp3inhibition
AT ormanmehmeta stationaryphasepersisterformationinescherichiacolicanbesuppressedbypiperacillinandpbp3inhibition
AT brynildsenmarkp stationaryphasepersisterformationinescherichiacolicanbesuppressedbypiperacillinandpbp3inhibition